Next Article in Journal
Endocrine-Disrupting Chemicals and Insulin Resistance in Children
Previous Article in Journal / Special Issue
Comprehensive Exonic Sequencing of Known Ataxia Genes in Episodic Ataxia
Open AccessCase Report

Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series

1
Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA 95817, USA
2
MIND Institute, University of California Davis, Sacramento, CA 95817, USA
3
Group on Congenital Malformations and Dysmorphology (MACOS), Faculty of Health, Universidad del Valle, Cali, Valle del Cauca 760041, Colombia
4
Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand
*
Author to whom correspondence should be addressed.
Biomedicines 2020, 8(5), 136; https://doi.org/10.3390/biomedicines8050136
Received: 6 May 2020 / Revised: 20 May 2020 / Accepted: 21 May 2020 / Published: 25 May 2020
Fragile X-associated tremor and ataxia syndrome (FXTAS) is a neurodegenerative disease developed by carriers of a premutation in the fragile X mental retardation 1 (FMR1) gene. The core clinical symptoms usually manifest in the early 60s, typically beginning with intention tremor followed by cerebellar ataxia. Ataxia can be the only symptom in approximately 20% of the patients. FXTAS has a slow progression, and patients usually experience advanced deterioration 15 to 25 years after the initial diagnosis. Common findings in brain imaging include substantial brain atrophy and white matter disease (WMD). We report three cases with an atypical clinical presentation, all presenting with gait problems as their initial manifestation and with ataxia as the dominant symptom without significant tremor, as well as a faster than usual clinical progression. Magnetic resonance imaging (MRI) was remarkable for severe brain atrophy, ventriculomegaly, thinning of the corpus callosum, and periventricular WMD. Two cases were diagnosed with definite FXTAS on the basis of clinical and radiological findings, with one individual also developing moderate dementia. Factors such as environmental exposure and general anesthesia could have contributed to their clinical deterioration. FXTAS should be considered in the differential diagnosis of patients presenting with ataxia, even in the absence of tremor, and FMR1 DNA testing should be sought in those with a family history of fragile X syndrome or premutation disorders. View Full-Text
Keywords: fragile X-associated tremor and ataxia syndrome; FMR1; ataxia; neurodegeneration fragile X-associated tremor and ataxia syndrome; FMR1; ataxia; neurodegeneration
Show Figures

Figure 1

MDPI and ACS Style

Salcedo-Arellano, M.J.; Cabal-Herrera, A.M.; Tassanakijpanich, N.; McLennan, Y.A.; Hagerman, R.J. Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series. Biomedicines 2020, 8, 136.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop